output stringlengths 5 24.3k | instruction stringlengths 33 308 | system stringclasses 1 value |
|---|---|---|
1. Anticholesteremic Agents [adverse effects, *therapeutic use]; 2. Cardiovascular Diseases [mortality, *prevention & control]; 3. Cause of Death; 4. Cholesterol [blood]; 5. Cholesterol, LDL [blood]; 6. Drug Therapy, Combination; 7. Ezetimibe [adverse effects, *therapeutic use]; 8. Fenofibrate [therapeutic use]; 9. Hydroxymethylglutaryl‐CoA Reductase Inhibitors [therapeutic use]; 10. Myocardial Infarction [mortality, prevention & control]; 11. Randomized Controlled Trials as Topic; 12. Simvastatin [adverse effects, therapeutic use]; 13. Stroke [mortality, prevention & control]; 14. Triglycerides [blood]; | Provide MESH terms for the study
Ezetimibe for the prevention of cardiovascular disease and all‐cause mortality events | You are a research assistant. Based on the question please provide appropriate answers |
1. Angiotensin-Converting Enzyme Inhibitors [adverse effects, *therapeutic use]; 2. Antihypertensive Agents [adverse effects, *therapeutic use]; 3. Calcium Channel Blockers [adverse effects, therapeutic use]; 4. Cause of Death; 5. Heart Failure [chemically induced, mortality, prevention & control]; 6. Hypertension [*drug therapy, mortality]; 7. Kidney Failure, Chronic [epidemiology]; 8. Myocardial Infarction [epidemiology]; 9. Randomized Controlled Trials as Topic; 10. Renin-Angiotensin System [*drug effects]; 11. Sodium Chloride Symporter Inhibitors [adverse effects, therapeutic use]; 12. Stroke [chemically induced, prevention & control]; | Provide MESH terms for the study
First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. *Bandages; 2. *Bone Marrow Transplantation; 3. Thromboangiitis Obliterans [*therapy]; 4. Walk Test; 5. Wound Healing; | Provide MESH terms for the study
Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease) | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Chlormethiazole [adverse effects, *therapeutic use]; 3. Diazepam [adverse effects, *therapeutic use]; 4. Disorders of Excessive Somnolence [chemically induced]; 5. GABA Agonists [adverse effects, *therapeutic use]; 6. Neuroprotective Agents [adverse effects, *therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Rhinitis [chemically induced]; 9. Stroke [*drug therapy, mortality]; 10. gamma‐Aminobutyric Acid [*therapeutic use]; | Provide MESH terms for the study
Gamma aminobutyric acid (GABA) receptor agonists for acute stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. *Thrombectomy [instrumentation, methods]; 2. Carotid Artery Thrombosis [drug therapy, surgery]; 3. Infarction, Middle Cerebral Artery [drug therapy, surgery]; 4. Intracranial Hemorrhages [epidemiology]; 5. Outcome Assessment, Health Care; 6. Randomized Controlled Trials as Topic; 7. Stroke [*drug therapy, etiology, mortality, *surgery]; 8. Thrombolytic Therapy [*methods]; | Provide MESH terms for the study
Percutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. *Early Ambulation [adverse effects, mortality]; 2. *Stroke Rehabilitation [mortality]; 3. Activities of Daily Living; 4. Length of Stay; 5. Network Meta‐Analysis; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Time Factors; | Provide MESH terms for the study
Very early versus delayed mobilisation after stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Antihypertensive Agents [adverse effects, *therapeutic use]; 2. Fetal Death; 3. Hypertension [*drug therapy, prevention & control]; 4. Infant, Premature; 5. Infant, Small for Gestational Age; 6. Maternal Death; 7. Placebo Effect; 8. Pre-Eclampsia [prevention & control]; 9. Pregnancy Complications, Cardiovascular [*drug therapy, prevention & control]; 10. Proteinuria [prevention & control]; 11. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy | You are a research assistant. Based on the question please provide appropriate answers |
1. *Exercise; 2. *Heart‐Assist Devices [adverse effects]; 3. *Resistance Training; 4. Cardiac Rehabilitation [*methods]; 5. Oxygen Consumption; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Exercise‐based cardiac rehabilitation for people with implantable ventricular assist devices | You are a research assistant. Based on the question please provide appropriate answers |
1. *Activities of Daily Living; 2. *Stroke Rehabilitation; 3. Arm; 4. Muscle Strength; 5. Robotics; 6. Stroke; | Provide MESH terms for the study
Electromechanical and robot‐assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Blood Circulation; 2. Cardiopulmonary Resuscitation [instrumentation, *methods, mortality]; 3. Heart Arrest [mortality, *therapy]; 4. Heart Massage [instrumentation, *methods, mortality]; 5. Hospitalization; 6. Patient Discharge; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Mechanical versus manual chest compressions for cardiac arrest | You are a research assistant. Based on the question please provide appropriate answers |
1. *Stents; 2. Aneurysm, Ruptured [mortality, surgery, *therapy]; 3. Brain Ischemia [epidemiology, etiology]; 4. Embolization, Therapeutic; 5. Endovascular Procedures [*methods]; 6. Intracranial Aneurysm [mortality, surgery, *therapy]; 7. Neurosurgical Procedures [adverse effects, methods]; 8. Postoperative Complications [epidemiology, etiology]; 9. Randomized Controlled Trials as Topic; 10. Recurrence; 11. Secondary Prevention [methods]; 12. Subarachnoid Hemorrhage [mortality, surgery, *therapy]; 13. Treatment Outcome; | Provide MESH terms for the study
Endovascular coiling versus neurosurgical clipping for people with aneurysmal subarachnoid haemorrhage | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Amputation, Surgical [statistics & numerical data]; 3. Fibrinolytic Agents [*therapeutic use]; 4. Ischemia [mortality, surgery, *therapy]; 5. Leg [*blood supply, surgery]; 6. Limb Salvage [statistics & numerical data]; 7. Outcome Assessment, Health Care; 8. Postoperative Hemorrhage [epidemiology]; 9. Randomized Controlled Trials as Topic; 10. *Thrombolytic Therapy; 11. Time Factors; 12. Tissue Plasminogen Activator [*therapeutic use]; 13. Urokinase-Type Plasminogen Activator [*therapeutic use]; | Provide MESH terms for the study
Surgery versus thrombolysis for initial management of acute limb ischaemia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Exercise; 2. *Fitness Trackers; 3. *Survivors; 4. Randomized Controlled Trials as Topic; 5. Stroke Rehabilitation [*instrumentation, methods]; 6. Time Factors; | Provide MESH terms for the study
Activity monitors for increasing physical activity in adult stroke survivors | You are a research assistant. Based on the question please provide appropriate answers |
1. *Secondary Prevention; 2. Angiotensin‐Converting Enzyme Inhibitors [therapeutic use]; 3. Antihypertensive Agents [*therapeutic use]; 4. Blood Pressure [drug effects]; 5. Cardiovascular Diseases [prevention & control]; 6. Cause of Death; 7. Dementia, Vascular [*prevention & control]; 8. Diuretics [therapeutic use]; 9. Hypertension [complications, *drug therapy]; 10. Ischemic Attack, Transient [*prevention & control]; 11. Primary Prevention; 12. Randomized Controlled Trials as Topic; 13. Recurrence; 14. Stroke [etiology, *prevention & control]; 15. Systole; 16. Time Factors; | Provide MESH terms for the study
Blood pressure‐lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack | You are a research assistant. Based on the question please provide appropriate answers |
1. *Elective Surgical Procedures [mortality]; 2. *Withholding Treatment; 3. Aspirin [administration & dosage]; 4. Cause of Death; 5. Clopidogrel; 6. Hemorrhage [*chemically induced, therapy]; 7. Ischemia [*chemically induced, therapy]; 8. Platelet Aggregation Inhibitors [*administration & dosage]; 9. Randomized Controlled Trials as Topic; 10. Ticlopidine [administration & dosage, analogs & derivatives]; | Provide MESH terms for the study
Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non‐cardiac surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. *Antibodies, Antiphospholipid; 2. *Primary Prevention; 3. Anticoagulants [*therapeutic use]; 4. Antiphospholipid Syndrome [*complications]; 5. Platelet Aggregation Inhibitors [*therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Thrombosis [*prevention & control]; | Provide MESH terms for the study
Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies | You are a research assistant. Based on the question please provide appropriate answers |
1. *Recovery of Function; 2. Activities of Daily Living; 3. Exercise Movement Techniques [instrumentation, *methods]; 4. Functional Laterality [physiology]; 5. Paresis [etiology, *rehabilitation]; 6. Randomized Controlled Trials as Topic; 7. Stroke [complications]; 8. Stroke Rehabilitation [*methods]; | Provide MESH terms for the study
Mirror therapy for improving motor function after stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. *Neuroprotection; 2. Bias; 3. Cerebral Arterial Diseases [complications]; 4. Extremities [blood supply]; 5. Ischemic Preconditioning [*methods, mortality]; 6. Randomized Controlled Trials as Topic; 7. Stroke [mortality, prevention & control, *therapy]; 8. Thrombolytic Therapy [mortality]; | Provide MESH terms for the study
Remote ischaemic conditioning for preventing and treating ischaemic stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. *Blood Pressure; 2. *Hypotension, Controlled; 3. Aortic Aneurysm, Abdominal [*complications]; 4. Aortic Rupture [*complications]; 5. Resuscitation [*methods]; 6. Shock, Hemorrhagic [etiology, *therapy]; 7. Systole; | Provide MESH terms for the study
Controlled hypotension versus normotensive resuscitation strategy for people with ruptured abdominal aortic aneurysm | You are a research assistant. Based on the question please provide appropriate answers |
1. Extracorporeal Shockwave Therapy [*methods]; 2. Leg Ulcer [*therapy]; 3. Varicose Ulcer [therapy]; 4. Wound Healing; | Provide MESH terms for the study
Extracorporeal shock wave therapy for the healing and management of venous leg ulcers | You are a research assistant. Based on the question please provide appropriate answers |
1. *Femoral Artery; 2. *Radial Artery; 3. Cardiac Catheterization [adverse effects, *methods]; 4. Coronary Angiography [*methods]; 5. Coronary Artery Disease [*diagnostic imaging, mortality, *surgery]; 6. Myocardial Infarction [etiology, mortality]; 7. Percutaneous Coronary Intervention [adverse effects, *methods]; | Provide MESH terms for the study
Transradial versus transfemoral approach for diagnostic coronary angiography and percutaneous coronary intervention in people with coronary artery disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta‐Antagonists [therapeutic use]; 2. Angiotensin‐Converting Enzyme Inhibitors [therapeutic use]; 3. Antihypertensive Agents [adverse effects, *therapeutic use]; 4. Calcium Channel Blockers [therapeutic use]; 5. Coronary Disease [prevention & control]; 6. Hypertension [*drug therapy, mortality]; 7. Randomized Controlled Trials as Topic; 8. Sodium Chloride Symporter Inhibitors [therapeutic use]; 9. Stroke [prevention & control]; 10. Thiazides [adverse effects, therapeutic use]; | Provide MESH terms for the study
First‐line drugs for hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. *Directly Observed Therapy; 2. Exercise Therapy [*methods, psychology]; 3. Intermittent Claudication [psychology, *therapy]; 4. Mental Health; 5. Pain Management [psychology]; 6. Pain Measurement; 7. Randomized Controlled Trials as Topic; 8. *Walking; | Provide MESH terms for the study
Supervised exercise therapy versus home‐based exercise therapy versus walking advice for intermittent claudication | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta-Antagonists [adverse effects, *therapeutic use]; 2. Anesthesia, General; 3. Arrhythmias, Cardiac [mortality, prevention & control]; 4. Bradycardia [chemically induced]; 5. Cardiovascular Diseases [chemically induced, mortality, *prevention & control]; 6. Cardiovascular Surgical Procedures [adverse effects, mortality]; 7. Cause of Death; 8. Cerebrovascular Disorders [mortality, prevention & control]; 9. Hypotension [chemically induced, mortality, prevention & control]; 10. Myocardial Infarction [mortality, prevention & control]; 11. Myocardial Ischemia [mortality, prevention & control]; 12. Postoperative Complications [mortality, *prevention & control]; 13. Randomized Controlled Trials as Topic; 14. Surgical Procedures, Operative [*adverse effects, mortality]; | Provide MESH terms for the study
Perioperative beta‐blockers for preventing surgery‐related mortality and morbidity | You are a research assistant. Based on the question please provide appropriate answers |
1. Atrial Fibrillation [*complications]; 2. Embolism [*prevention & control]; 3. Factor Xa Inhibitors [*therapeutic use]; 4. Intracranial Embolism [*prevention & control]; 5. Randomized Controlled Trials as Topic; 6. Stroke [prevention & control]; 7. Vitamin K [*antagonists & inhibitors]; | Provide MESH terms for the study
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation | You are a research assistant. Based on the question please provide appropriate answers |
1. Cholesterol [*blood]; 2. Cholesterol, LDL [blood]; 3. Controlled Before‐After Studies; 4. Dose‐Response Relationship, Drug; 5. Fatty Acids, Monounsaturated [*administration & dosage]; 6. Fluvastatin; 7. Hydroxymethylglutaryl‐CoA Reductase Inhibitors [*administration & dosage]; 8. Indoles [*administration & dosage]; 9. Randomized Controlled Trials as Topic; 10. Triglycerides [blood]; | Provide MESH terms for the study
Fluvastatin for lowering lipids | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Inflammatory Agents, Non‐Steroidal [*therapeutic use]; 2. Anticoagulants [*therapeutic use]; 3. Factor Xa Inhibitors [therapeutic use]; 4. Fondaparinux; 5. Hemorrhage [chemically induced]; 6. Heparin, Low‐Molecular‐Weight [*therapeutic use]; 7. Polysaccharides [therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Rivaroxaban [therapeutic use]; 10. Stockings, Compression; 11. Thrombectomy; 12. Thromboembolism [prevention & control]; 13. Thrombophlebitis [drug therapy, surgery, *therapy]; 14. Venous Thromboembolism [*prevention & control]; | Provide MESH terms for the study
Treatment for superficial thrombophlebitis of the leg | You are a research assistant. Based on the question please provide appropriate answers |
1. Arterial Occlusive Diseases [*surgery]; 2. Blood Vessel Prosthesis Implantation; 3. Femoral Artery [*surgery]; 4. Intermittent Claudication [surgery]; 5. Leg [*blood supply]; 6. Polyethylene Terephthalates; 7. Polytetrafluoroethylene; 8. Popliteal Artery [*surgery]; 9. Randomized Controlled Trials as Topic; 10. Saphenous Vein [*transplantation]; 11. Transplantation, Autologous; 12. Umbilical Veins [*transplantation]; 13. Vascular Surgical Procedures; | Provide MESH terms for the study
Graft type for femoro‐popliteal bypass surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. *Pulmonary Artery; 2. Cardiac Surgical Procedures [*adverse effects]; 3. Cardiopulmonary Bypass [*adverse effects]; 4. Cause of Death; 5. Lung [*blood supply]; 6. Lung Diseases [etiology, *prevention & control]; 7. Organ Preservation Solutions; 8. Oxygen Consumption; 9. Perfusion [*methods]; 10. Postoperative Complications [*prevention & control]; 11. Pulmonary Circulation; 12. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Pulmonary artery perfusion versus no perfusion during cardiopulmonary bypass for open heart surgery in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. *Exercise; 2. Angina, Stable [*rehabilitation]; 3. Cardiac Rehabilitation [*methods]; 4. Cause of Death; 5. Hospitalization [statistics & numerical data]; 6. Myocardial Infarction [epidemiology]; 7. Publication Bias; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Exercise‐based cardiac rehabilitation for adults with stable angina | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [*therapeutic use]; 2. Antibiotic Prophylaxis [methods]; 3. Bacterial Infections [mortality, *prevention & control]; 4. Brain Ischemia [complications]; 5. Pneumonia [epidemiology]; 6. Randomized Controlled Trials as Topic; 7. Stroke [*complications, mortality]; 8. Urinary Tract Infections [epidemiology]; | Provide MESH terms for the study
Antibiotic therapy for preventing infections in people with acute stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Alprostadil [therapeutic use]; 2. Amputation, Surgical [statistics & numerical data]; 3. Epoprostenol [therapeutic use]; 4. Iloprost [therapeutic use]; 5. Ischemia [*drug therapy, mortality]; 6. Leg [*blood supply, surgery]; 7. Leg Ulcer [drug therapy]; 8. Nafronyl [therapeutic use]; 9. Nicotinic Acids [therapeutic use]; 10. Pentoxifylline [therapeutic use]; 11. Peripheral Vascular Diseases [*drug therapy]; 12. Prostaglandins [adverse effects, *therapeutic use]; 13. Randomized Controlled Trials as Topic; 14. Vasodilator Agents [therapeutic use]; | Provide MESH terms for the study
Prostanoids for critical limb ischaemia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Home Care Services; 2. *Hospitalization; 3. Cost‐Benefit Analysis; 4. Fibrinolytic Agents [*therapeutic use]; 5. Hemorrhage [chemically induced]; 6. Heparin [adverse effects, *therapeutic use]; 7. Heparin, Low‐Molecular‐Weight [adverse effects, therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Recurrence; 10. Secondary Prevention; 11. Thrombolytic Therapy [standards]; 12. Venous Thrombosis [*drug therapy, mortality]; | Provide MESH terms for the study
Home versus in‐patient treatment for deep vein thrombosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Amputation, Surgical [statistics & numerical data]; 2. Ankle Brachial Index; 3. Exercise Therapy [*methods]; 4. Intermittent Claudication [*therapy]; 5. Pain Management [methods]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Time Factors; 9. Walking; | Provide MESH terms for the study
Exercise for intermittent claudication | You are a research assistant. Based on the question please provide appropriate answers |
1. *Secondary Prevention; 2. Administration, Oral; 3. Anticoagulants [*administration & dosage, adverse effects]; 4. Aspirin [administration & dosage, adverse effects]; 5. Hemorrhage [chemically induced]; 6. Myocardial Infarction [epidemiology]; 7. Randomized Controlled Trials as Topic; 8. Recurrence; 9. Rivaroxaban [administration & dosage, adverse effects]; 10. Stroke [epidemiology]; 11. Venous Thromboembolism [drug therapy, mortality, *prevention & control]; 12. Warfarin [administration & dosage, adverse effects]; | Provide MESH terms for the study
Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism | You are a research assistant. Based on the question please provide appropriate answers |
1. Aspirin [adverse effects, *therapeutic use]; 2. Cardiovascular Diseases [mortality, *prevention & control]; 3. Clopidogrel; 4. Drug Therapy, Combination [adverse effects, methods]; 5. Hemorrhage [chemically induced]; 6. Platelet Aggregation Inhibitors [adverse effects, *therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Ticlopidine [adverse effects, *analogs & derivatives, therapeutic use]; | Provide MESH terms for the study
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events | You are a research assistant. Based on the question please provide appropriate answers |
1. Calcium Channel Blockers [administration & dosage, *therapeutic use]; 2. Dihydropyridines [administration & dosage, therapeutic use]; 3. Nifedipine [administration & dosage, therapeutic use]; 4. Pain Management; 5. Placebos [therapeutic use]; 6. Publication Bias; 7. Randomized Controlled Trials as Topic; 8. Raynaud Disease [*drug therapy, etiology]; 9. Severity of Illness Index; | Provide MESH terms for the study
Calcium channel blockers for primary and secondary Raynaud's phenomenon | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Thrombolytic Therapy [*methods]; 3. Upper Extremity Deep Vein Thrombosis [*drug therapy]; | Provide MESH terms for the study
Thrombolysis for acute upper extremity deep vein thrombosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [administration & dosage, adverse effects, *therapeutic use]; 2. Biotin [administration & dosage, adverse effects, *analogs & derivatives, therapeutic use]; 3. Fondaparinux; 4. Hemorrhage [chemically induced]; 5. Heparin, Low‐Molecular‐Weight [therapeutic use]; 6. Oligosaccharides [administration & dosage, adverse effects, *therapeutic use]; 7. Polysaccharides [administration & dosage, adverse effects, *therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Recurrence; 10. Time Factors; 11. Venous Thrombosis [*drug therapy]; | Provide MESH terms for the study
Pentasaccharides for the treatment of deep vein thrombosis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Video Games; 2. Activities of Daily Living; 3. Gait; 4. Postural Balance; 5. Psychomotor Performance; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Stroke [psychology]; 9. Stroke Rehabilitation [*methods]; 10. Therapy, Computer‐Assisted [*methods]; 11. Upper Extremity; 12. User‐Computer Interface; | Provide MESH terms for the study
Virtual reality for stroke rehabilitation | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Anticoagulants [adverse effects, *therapeutic use]; 3. Antithrombins [adverse effects, therapeutic use]; 4. Atrial Fibrillation [*complications]; 5. Dabigatran [adverse effects, therapeutic use]; 6. Embolism [*prevention & control]; 7. Hemorrhage [chemically induced, epidemiology]; 8. Pyrazoles [adverse effects, therapeutic use]; 9. Pyridines [adverse effects, therapeutic use]; 10. Pyridones [adverse effects, therapeutic use]; 11. Randomized Controlled Trials as Topic; 12. Renal Insufficiency, Chronic [*complications]; 13. Rivaroxaban [adverse effects, therapeutic use]; 14. Stroke [*prevention & control]; 15. Thiazoles [adverse effects, therapeutic use]; 16. Warfarin [adverse effects, therapeutic use]; | Provide MESH terms for the study
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Adenosine [adverse effects, *therapeutic use]; 2. Anti‐Arrhythmia Agents [adverse effects, *therapeutic use]; 3. Calcium Channel Blockers [adverse effects, *therapeutic use]; 4. Emergency Service, Hospital [statistics & numerical data]; 5. Hypotension [chemically induced]; 6. Randomized Controlled Trials as Topic; 7. Tachycardia, Supraventricular [*drug therapy]; 8. Verapamil [adverse effects, therapeutic use]; | Provide MESH terms for the study
Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Bandages; 2. Postthrombotic Syndrome [etiology, *prevention & control]; 3. Quality of Life; 4. Randomized Controlled Trials as Topic; 5. Venous Thrombosis [complications]; | Provide MESH terms for the study
Compression therapy for prevention of post‐thrombotic syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [therapeutic use]; 2. Antitubercular Agents [therapeutic use]; 3. Cause of Death; 4. Colchicine [therapeutic use]; 5. Drainage; 6. HIV Seronegativity; 7. HIV Seropositivity [drug therapy]; 8. Immunotherapy; 9. Pericardiectomy; 10. Pericarditis, Tuberculous [complications, *drug therapy, mortality, *surgery]; 11. Pericardium [surgery]; 12. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Interventions for treating tuberculous pericarditis | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Coronary Syndrome [mortality, *therapy]; 2. Cause of Death; 3. *Drug-Eluting Stents [adverse effects]; 4. Randomized Controlled Trials as Topic; 5. *Stents [adverse effects]; | Provide MESH terms for the study
Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. *Walking Speed; 2. Body Weight; 3. Exercise Therapy [instrumentation, *methods]; 4. Orthotic Devices; 5. Patient Dropouts [statistics & numerical data]; 6. Randomized Controlled Trials as Topic; 7. Stroke Rehabilitation [*methods]; 8. Walking; 9. Weight‐Bearing; | Provide MESH terms for the study
Treadmill training and body weight support for walking after stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Antihypertensive Agents [adverse effects, *therapeutic use]; 2. Bendroflumethiazide [therapeutic use]; 3. Blood Pressure [drug effects]; 4. Cause of Death; 5. Coronary Disease [mortality, prevention & control]; 6. Hypertension [*drug therapy, mortality]; 7. Methyldopa [therapeutic use]; 8. Myocardial Infarction [mortality, prevention & control]; 9. Patient Dropouts [statistics & numerical data]; 10. Propranolol [therapeutic use]; 11. Randomized Controlled Trials as Topic; 12. Stroke [mortality, prevention & control]; | Provide MESH terms for the study
Pharmacotherapy for hypertension in adults aged 18 to 59 years | You are a research assistant. Based on the question please provide appropriate answers |
1. Antihypertensive Agents [*therapeutic use]; 2. Blood Pressure [*drug effects]; 3. Blood Pressure Determination; 4. Cardiovascular Diseases [epidemiology]; 5. Cause of Death; 6. Hospitalization [statistics & numerical data]; 7. Hypertension [*drug therapy, mortality]; 8. Patient Dropouts [statistics & numerical data]; 9. Randomized Controlled Trials as Topic; 10. Reference Values; 11. Stroke [epidemiology]; 12. Systole; | Provide MESH terms for the study
Blood pressure targets for hypertension in older adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [adverse effects, *therapeutic use]; 2. Cause of Death; 3. Hemorrhage [chemically induced]; 4. Heparin, Low‐Molecular‐Weight [adverse effects, *therapeutic use]; 5. Immobilization [*adverse effects]; 6. Leg Injuries [*therapy]; 7. Pulmonary Embolism [epidemiology, prevention & control]; 8. Randomized Controlled Trials as Topic; 9. Venous Thromboembolism [*prevention & control]; 10. Venous Thrombosis [epidemiology, prevention & control]; | Provide MESH terms for the study
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [adverse effects, *therapeutic use]; 2. Hemorrhage [chemically induced, epidemiology]; 3. Heparin, Low‐Molecular‐Weight [adverse effects, *therapeutic use]; 4. Incidence; 5. Odds Ratio; 6. Randomized Controlled Trials as Topic; 7. Recurrence; 8. Venous Thromboembolism [*drug therapy, mortality]; 9. Venous Thrombosis [drug therapy]; 10. Vitamin K [*antagonists & inhibitors]; | Provide MESH terms for the study
Vitamin K antagonists versus low‐molecular‐weight heparin for the long term treatment of symptomatic venous thromboembolism | You are a research assistant. Based on the question please provide appropriate answers |
1. *Activities of Daily Living; 2. Depression [epidemiology]; 3. *Occupational Therapy; 4. Randomized Controlled Trials as Topic; 5. Stroke [mortality, psychology]; 6. *Stroke Rehabilitation; | Provide MESH terms for the study
Occupational therapy for adults with problems in activities of daily living after stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. *Length of Stay; 2. *Patient Discharge [economics]; 3. *Stroke Rehabilitation; 4. Cost‐Benefit Analysis; 5. Home Care Services, Hospital‐Based [economics, *organization & administration]; 6. Home Nursing [economics, organization & administration]; 7. Patient Readmission [statistics & numerical data]; 8. Randomized Controlled Trials as Topic; 9. Stroke [economics, mortality]; | Provide MESH terms for the study
Early supported discharge services for people with acute stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Pain [psychology, *therapy]; 2. Analgesics [therapeutic use]; 3. Behavior Therapy [*methods]; 4. Cardiac Surgical Procedures [*adverse effects]; 5. Cognitive Behavioral Therapy; 6. Pain Measurement; 7. Pain, Postoperative [psychology, *therapy]; 8. Randomized Controlled Trials as Topic; 9. Relaxation Therapy [*methods]; 10. Stress, Psychological [epidemiology]; | Provide MESH terms for the study
Psychological interventions for acute pain after open heart surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. *Primary Prevention; 2. *Secondary Prevention; 3. Cardiovascular Diseases [mortality, *prevention & control]; 4. Myocardial Infarction [mortality, prevention & control]; 5. Niacin [*administration & dosage, adverse effects]; 6. Randomized Controlled Trials as Topic [statistics & numerical data]; 7. Stroke [mortality, prevention & control]; 8. Vasodilator Agents [*administration & dosage, adverse effects]; | Provide MESH terms for the study
Niacin for primary and secondary prevention of cardiovascular events | You are a research assistant. Based on the question please provide appropriate answers |
1. Amputation, Surgical [statistics & numerical data]; 2. Fibroblast Growth Factors [adverse effects, *therapeutic use]; 3. Hepatocyte Growth Factor [adverse effects, *therapeutic use]; 4. Intermittent Claudication [*drug therapy, mortality]; 5. Leg [blood supply, surgery]; 6. Leg Ulcer [drug therapy]; 7. Peripheral Arterial Disease [*drug therapy, mortality]; 8. Randomized Controlled Trials as Topic; 9. Vascular Endothelial Growth Factor A [adverse effects, *therapeutic use]; | Provide MESH terms for the study
Growth factors for angiogenesis in peripheral arterial disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Walking Speed; 2. Arm [physiology]; 3. Exercise Therapy [adverse effects, *methods]; 4. Gait [physiology]; 5. Postural Balance [physiology]; 6. Randomized Controlled Trials as Topic; 7. Recovery of Function; 8. Stroke Rehabilitation [*methods]; 9. Walk Test; | Provide MESH terms for the study
Circuit class therapy for improving mobility after stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Aortic Aneurysm, Abdominal [*surgery]; 2. Elective Surgical Procedures [adverse effects, *methods]; 3. Endovascular Procedures [adverse effects, *methods]; 4. Laparoscopy [adverse effects, *methods]; 5. Length of Stay; 6. Operative Time; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Laparoscopic surgery for elective abdominal aortic aneurysm repair | You are a research assistant. Based on the question please provide appropriate answers |
1. Cause of Death; 2. Coronary Stenosis [complications, mortality, *surgery]; 3. Myocardial Revascularization [adverse effects, *methods, mortality]; 4. Randomized Controlled Trials as Topic; 5. ST Elevation Myocardial Infarction [etiology, mortality, *surgery]; | Provide MESH terms for the study
Complete versus culprit‐only revascularisation in ST elevation myocardial infarction with multi‐vessel disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Arginine [*therapeutic use]; 3. Brain Ischemia [drug therapy]; 4. Enzyme Inhibitors [*therapeutic use]; 5. Headache [chemically induced]; 6. Nitric Oxide Donors [adverse effects, *therapeutic use]; 7. Nitric Oxide Synthase [*antagonists & inhibitors]; 8. Nitroglycerin [adverse effects, *therapeutic use]; 9. Quality of Life; 10. Randomized Controlled Trials as Topic; 11. Stroke [*drug therapy, mortality]; | Provide MESH terms for the study
Nitric oxide donors (nitrates), L‐arginine, or nitric oxide synthase inhibitors for acute stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Anticoagulants [*administration & dosage, adverse effects]; 3. Anxiety [prevention & control]; 4. Atrial Fibrillation [blood, *complications]; 5. Chronic Disease; 6. Decision Support Techniques; 7. Drug Monitoring [*methods, standards]; 8. *International Normalized Ratio [standards]; 9. Medication Adherence; 10. *Patient Education as Topic; 11. Randomized Controlled Trials as Topic; 12. Self Care [methods]; 13. Stroke [blood, etiology, *prevention & control]; | Provide MESH terms for the study
Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation | You are a research assistant. Based on the question please provide appropriate answers |
1. Amides [administration & dosage, adverse effects, *therapeutic use]; 2. Antihypertensive Agents [administration & dosage, adverse effects, *therapeutic use]; 3. Blood Pressure [*drug effects]; 4. Diarrhea [chemically induced]; 5. Fumarates [administration & dosage, adverse effects, *therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Renin [*antagonists & inhibitors]; | Provide MESH terms for the study
Blood pressure lowering efficacy of renin inhibitors for primary hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Anticoagulants [*therapeutic use]; 3. Brain Ischemia [drug therapy]; 4. Cause of Death; 5. Fibrinolytic Agents [*therapeutic use]; 6. Hemorrhage [chemically induced, epidemiology]; 7. Heparin [therapeutic use]; 8. Heparin, Low‐Molecular‐Weight [*therapeutic use]; 9. Heparinoids [*therapeutic use]; 10. Pulmonary Embolism [epidemiology]; 11. Randomized Controlled Trials as Topic; 12. Stroke [*drug therapy, mortality]; 13. Venous Thrombosis [epidemiology]; | Provide MESH terms for the study
Low‐molecular‐weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. *Exercise; 2. *Exercise Tolerance; 3. Cardiac Rehabilitation [*methods]; 4. Heart Transplantation [*rehabilitation]; 5. High‐Intensity Interval Training; 6. Physical Conditioning, Human [*methods]; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Exercise‐based cardiac rehabilitation in heart transplant recipients | You are a research assistant. Based on the question please provide appropriate answers |
1. Blood Circulation [physiology]; 2. Cardiopulmonary Resuscitation [*methods, mortality]; 3. Emergency Medical Technicians; 4. Heart Massage [*methods]; 5. Hospitalization; 6. Out-of-Hospital Cardiac Arrest [classification, etiology, mortality, *therapy]; 7. Randomized Controlled Trials as Topic; 8. Telephone; 9. Thorax; 10. Treatment Outcome; | Provide MESH terms for the study
Continuous chest compression versus interrupted chest compression for cardiopulmonary resuscitation of non‐asphyxial out‐of‐hospital cardiac arrest | You are a research assistant. Based on the question please provide appropriate answers |
1. Angioplasty, Balloon, Coronary [statistics & numerical data]; 2. Ascorbic Acid [*administration & dosage]; 3. Cardiovascular Diseases [epidemiology, *prevention & control]; 4. Coronary Artery Bypass [statistics & numerical data]; 5. *Dietary Supplements; 6. Myocardial Infarction [epidemiology]; 7. Physicians; 8. Primary Prevention [*methods]; 9. Publication Bias; 10. Randomized Controlled Trials as Topic; 11. Stroke [epidemiology]; 12. Vitamins [*administration & dosage]; | Provide MESH terms for the study
Vitamin C supplementation for the primary prevention of cardiovascular disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticholesteremic Agents [therapeutic use]; 2. Antihypertensive Agents [therapeutic use]; 3. Blood Pressure; 4. Cardiovascular Diseases [blood, etiology, *prevention & control]; 5. Cholesterol [blood]; 6. Heart Diseases [prevention & control]; 7. Primary Prevention [*methods]; 8. Randomized Controlled Trials as Topic; 9. Risk Assessment; 10. Risk Factors; 11. Stroke [prevention & control]; | Provide MESH terms for the study
Risk scoring for the primary prevention of cardiovascular disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticholesteremic Agents [*administration & dosage, adverse effects]; 2. Antihypertensive Agents [*administration & dosage, adverse effects]; 3. Aspirin [*administration & dosage, adverse effects]; 4. Blood Pressure [drug effects]; 5. Cardiovascular Diseases [mortality, *prevention & control]; 6. Cause of Death; 7. Cholesterol [blood]; 8. Drug Combinations; 9. Placebo Effect; 10. Platelet Aggregation Inhibitors [*administration & dosage, adverse effects]; 11. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Fixed‐dose combination therapy for the prevention of atherosclerotic cardiovascular diseases | You are a research assistant. Based on the question please provide appropriate answers |
1. Antihypertensive Agents [*administration & dosage, adverse effects]; 2. Blood Pressure [drug effects]; 3. Eplerenone; 4. Essential Hypertension; 5. Hypertension [complications, *drug therapy]; 6. Patient Dropouts [statistics & numerical data]; 7. Randomized Controlled Trials as Topic; 8. Spironolactone [administration & dosage, adverse effects, *analogs & derivatives]; | Provide MESH terms for the study
Eplerenone for hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [*administration & dosage, adverse effects]; 2. Hemorrhage [chemically induced]; 3. Heparin [administration & dosage, adverse effects]; 4. Heparin, Low‐Molecular‐Weight [*administration & dosage, adverse effects]; 5. Injections, Subcutaneous; 6. Pulmonary Embolism [*drug therapy, mortality]; 7. Randomized Controlled Trials as Topic; 8. Recurrence; 9. Venous Thrombosis [*drug therapy, mortality]; | Provide MESH terms for the study
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism | You are a research assistant. Based on the question please provide appropriate answers |
1. Angina, Stable [*drug therapy, mortality, prevention & control]; 2. Cardiovascular Agents [administration & dosage, adverse effects, *therapeutic use]; 3. Cause of Death; 4. Incidence; 5. Myocardial Infarction [epidemiology]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Ranolazine [administration & dosage, adverse effects, *therapeutic use]; | Provide MESH terms for the study
Ranolazine for stable angina pectoris | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta‐Antagonists [adverse effects, *therapeutic use]; 2. Angiotensin Receptor Antagonists [therapeutic use]; 3. Antihypertensive Agents [adverse effects, *therapeutic use]; 4. Atenolol [therapeutic use]; 5. Calcium Channel Blockers [therapeutic use]; 6. Coronary Disease [prevention & control]; 7. Diuretics [therapeutic use]; 8. Heart Arrest [prevention & control]; 9. Hypertension [*drug therapy, mortality]; 10. Randomized Controlled Trials as Topic; 11. Stroke [prevention & control]; | Provide MESH terms for the study
Beta‐blockers for hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. Antihypertensive Agents [therapeutic use]; 2. Aortic Aneurysm, Abdominal [*complications, mortality]; 3. Cardiovascular Agents [*therapeutic use]; 4. Cardiovascular Diseases [mortality, *prevention & control]; 5. Cause of Death; 6. Metoprolol [*therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Risk Factors; | Provide MESH terms for the study
Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm | You are a research assistant. Based on the question please provide appropriate answers |
1. Adult Stem Cells [transplantation]; 2. Arrhythmias, Cardiac [epidemiology]; 3. Bone Marrow Cells [cytology]; 4. Chronic Disease; 5. Heart Failure [mortality, *surgery]; 6. Hospitalization [statistics & numerical data]; 7. Myocardial Infarction [epidemiology]; 8. Myocardial Ischemia [mortality, *surgery]; 9. Patient Readmission; 10. Randomized Controlled Trials as Topic; 11. Stem Cell Transplantation [adverse effects, *methods, mortality]; 12. Stroke Volume [physiology]; | Provide MESH terms for the study
Stem cell therapy for chronic ischaemic heart disease and congestive heart failure | You are a research assistant. Based on the question please provide appropriate answers |
1. *Caregivers; 2. *Postural Balance; 3. *Quality of Life; 4. Activities of Daily Living; 5. Exercise Therapy [*methods]; 6. Randomized Controlled Trials as Topic; 7. Stroke Rehabilitation [*methods]; 8. Walking; | Provide MESH terms for the study
Caregiver‐mediated exercises for improving outcomes after stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Antihypertensive Agents [administration & dosage, *therapeutic use]; 2. Blood Pressure [*drug effects]; 3. Heart Rate [drug effects]; 4. Hypertension [*drug therapy]; 5. Randomized Controlled Trials as Topic; 6. Rauwolfia [chemistry]; 7. Reserpine [administration & dosage, *therapeutic use]; | Provide MESH terms for the study
Blood pressure‐lowering efficacy of reserpine for primary hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. Cardiovascular Diseases [prevention & control]; 2. Cholesterol [blood]; 3. Cholesterol, LDL [blood]; 4. Hypolipidemic Agents [*therapeutic use]; 5. *Medication Adherence [statistics & numerical data]; 6. Randomized Controlled Trials as Topic; 7. Reminder Systems; | Provide MESH terms for the study
Interventions to improve adherence to lipid‐lowering medication | You are a research assistant. Based on the question please provide appropriate answers |
1. *Oxygen Inhalation Therapy [adverse effects, mortality]; 2. Air; 3. Analgesics [therapeutic use]; 4. Cause of Death; 5. Intention to Treat Analysis; 6. Myocardial Infarction [mortality, pathology, *therapy]; 7. Pain Measurement [methods]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Oxygen therapy for acute myocardial infarction | You are a research assistant. Based on the question please provide appropriate answers |
1. *Saphenous Vein [surgery]; 2. Catheter Ablation [*methods]; 3. Endovascular Procedures [*methods]; 4. Laser Therapy [*methods]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Recurrence; 8. Sclerotherapy [*methods]; 9. Ultrasonography, Interventional [methods]; 10. Varicose Veins [surgery, *therapy]; | Provide MESH terms for the study
Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins | You are a research assistant. Based on the question please provide appropriate answers |
1. *Catheter Ablation [adverse effects]; 2. Anti‐Arrhythmia Agents [*therapeutic use]; 3. Atrial Fibrillation [*drug therapy, *surgery]; 4. Bradycardia [therapy]; 5. Electric Countershock [statistics & numerical data]; 6. Hospitalization [statistics & numerical data]; 7. Pacemaker, Artificial [statistics & numerical data]; 8. Randomized Controlled Trials as Topic; 9. Safety; 10. Treatment Outcome; | Provide MESH terms for the study
Efficacy and safety of ablation for people with non‐paroxysmal atrial fibrillation | You are a research assistant. Based on the question please provide appropriate answers |
1. *Primary Prevention [standards]; 2. Atorvastatin [therapeutic use]; 3. Bezafibrate [therapeutic use]; 4. Cardiovascular Diseases [mortality, *prevention & control]; 5. Clofibric Acid [analogs & derivatives, therapeutic use]; 6. Fenofibrate [therapeutic use]; 7. Gemfibrozil [therapeutic use]; 8. Hypolipidemic Agents [adverse effects, *therapeutic use]; 9. Myocardial Infarction [epidemiology, mortality]; 10. Simvastatin [therapeutic use]; 11. Stroke [epidemiology, mortality]; | Provide MESH terms for the study
Fibrates for primary prevention of cardiovascular disease events | You are a research assistant. Based on the question please provide appropriate answers |
1. *Catheterization, Peripheral; 2. *Endovascular Procedures; 3. *Femoral Vein; 4. *Iliac Vein; 5. Thrombectomy [*methods]; 6. Venous Thrombosis [*therapy]; | Provide MESH terms for the study
Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis | You are a research assistant. Based on the question please provide appropriate answers |
1. Baclofen [therapeutic use]; 2. Botulinum Toxins, Type A [therapeutic use]; 3. Clonidine [analogs & derivatives, therapeutic use]; 4. Diazepam [therapeutic use]; 5. Muscle Relaxants, Central [therapeutic use]; 6. Muscle Spasticity [*drug therapy]; 7. Randomized Controlled Trials as Topic; 8. Stroke [*complications]; 9. Tolperisone [therapeutic use]; | Provide MESH terms for the study
Pharmacological interventions other than botulinum toxin for spasticity after stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [*therapeutic use]; 2. Heart Failure [*complications, mortality]; 3. Platelet Aggregation Inhibitors [*therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Thromboembolism [*drug therapy, etiology]; | Provide MESH terms for the study
Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm | You are a research assistant. Based on the question please provide appropriate answers |
1. *Health Behavior; 2. *Quality of Life; 3. *Stroke Rehabilitation; 4. Health Services Needs and Demand; 5. Independent Living; 6. Self Care [*methods]; 7. Self Efficacy; | Provide MESH terms for the study
Self management programmes for quality of life in people with stroke | You are a research assistant. Based on the question please provide appropriate answers |
1. *Jugular Veins [diagnostic imaging]; 2. *Subclavian Vein [diagnostic imaging]; 3. *Vascular Access Devices [adverse effects]; 4. Arm [*blood supply]; 5. Catheter‐Related Infections; 6. Catheterization, Central Venous [adverse effects, *methods]; 7. Intention to Treat Analysis; 8. Pneumothorax [etiology]; 9. Randomized Controlled Trials as Topic; 10. Ultrasonography, Interventional [methods]; 11. Veins [diagnostic imaging]; 12. Venous Cutdown [adverse effects, *methods]; | Provide MESH terms for the study
Venous cutdown versus the Seldinger technique for placement of totally implantable venous access ports | You are a research assistant. Based on the question please provide appropriate answers |
1. *Emergency Treatment; 2. Anticoagulants [*administration & dosage]; 3. Aortic Aneurysm, Abdominal [*surgery]; 4. Aortic Rupture [*surgery]; 5. Emergencies; 6. Heparin [*administration & dosage]; 7. Injections, Intravenous; 8. Intraoperative Period; | Provide MESH terms for the study
Intravenous heparin during ruptured abdominal aortic aneurysmal repair | You are a research assistant. Based on the question please provide appropriate answers |
1. Amputation, Surgical [statistics & numerical data]; 2. Angioplasty, Balloon [*methods, mortality]; 3. Drug‐Eluting Stents; 4. Femoral Artery; 5. Lower Extremity [*blood supply]; 6. Paclitaxel [*therapeutic use]; 7. Peripheral Arterial Disease [mortality, *therapy]; 8. Popliteal Artery; 9. Randomized Controlled Trials as Topic; 10. Tibial Arteries; 11. Time Factors; 12. Vascular Patency; | Provide MESH terms for the study
Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs | You are a research assistant. Based on the question please provide appropriate answers |
1. Carbazoles [*therapeutic use]; 2. Cardiotonic Agents [adverse effects, *therapeutic use]; 3. Carvedilol; 4. Chagas Cardiomyopathy [*complications]; 5. Heart Failure [*drug therapy, etiology]; 6. Propanolamines [*therapeutic use]; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Rosuvastatin Calcium [*therapeutic use]; 10. Survival Analysis; | Provide MESH terms for the study
Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [adverse effects, *therapeutic use]; 2. Fibrinolytic Agents [adverse effects, *therapeutic use]; 3. Glycosaminoglycans [adverse effects, *therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Varicose Ulcer [*drug therapy]; | Provide MESH terms for the study
Sulodexide for treating venous leg ulcers | You are a research assistant. Based on the question please provide appropriate answers |
1. Angina, Unstable [mortality, surgery, *therapy]; 2. Angioplasty, Balloon, Coronary [*adverse effects]; 3. Cause of Death; 4. Coronary Angiography; 5. Coronary Artery Disease [therapy]; 6. Myocardial Infarction [mortality, surgery, *therapy]; 7. Platelet Glycoprotein GPIIb‐IIIa Complex [antagonists & inhibitors]; 8. Randomized Controlled Trials as Topic; 9. Sex Factors; 10. Stents; | Provide MESH terms for the study
Routine invasive strategies versus selective invasive strategies for unstable angina and non‐ST elevation myocardial infarction in the stent era | You are a research assistant. Based on the question please provide appropriate answers |
1. *Electrodes, Implanted; 2. Electrocardiography [*instrumentation]; 3. Quality of Life; 4. Randomized Controlled Trials as Topic; 5. Recurrence; 6. Syncope [*diagnosis, etiology, mortality]; | Provide MESH terms for the study
Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticoagulants [*therapeutic use]; 2. Arthroplasty, Replacement, Hip [*adverse effects]; 3. Arthroplasty, Replacement, Knee [*adverse effects]; 4. Hemorrhage [chemically induced]; 5. Heparin [*therapeutic use]; 6. Hip Fractures [*surgery]; 7. Randomized Controlled Trials as Topic; 8. Venous Thromboembolism [*prevention & control]; 9. Vitamin K [*antagonists & inhibitors]; | Provide MESH terms for the study
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair | You are a research assistant. Based on the question please provide appropriate answers |
1. *Death, Sudden, Cardiac; 2. *Neuroprotection; 3. Emergency Medical Services [*methods]; 4. Hypothermia, Induced [adverse effects, *methods]; 5. Hypoxia, Brain [*prevention & control]; 6. Out‐of‐Hospital Cardiac Arrest [*mortality, *therapy]; 7. Randomized Controlled Trials as Topic; 8. Recurrence; 9. Risk; | Provide MESH terms for the study
Pre‐hospital versus in‐hospital initiation of cooling for survival and neuroprotection after out‐of‐hospital cardiac arrest | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta‐Antagonists [administration & dosage, *therapeutic use]; 2. Antihypertensive Agents [administration & dosage, *therapeutic use]; 3. Blood Pressure [drug effects]; 4. Diastole [drug effects]; 5. Essential Hypertension; 6. Heart Rate [drug effects]; 7. Hypertension [*drug therapy]; 8. Randomized Controlled Trials as Topic; 9. Systole [drug effects]; | Provide MESH terms for the study
Blood pressure lowering efficacy of beta‐1 selective beta blockers for primary hypertension | You are a research assistant. Based on the question please provide appropriate answers |
1. Antihypertensive Agents [*therapeutic use]; 2. Death, Sudden, Cardiac [*prevention & control]; 3. Hypertension [complications, *drug therapy]; 4. Myocardial Infarction [*prevention & control]; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals | You are a research assistant. Based on the question please provide appropriate answers |
1. *Patient Compliance; 2. *Self‐Help Groups; 3. Behavior Therapy; 4. Chronic Disease; 5. Compression Bandages; 6. Counseling [methods]; 7. Exercise; 8. Goals; 9. Interpersonal Relations; 10. Practice Patterns, Nurses'; 11. Randomized Controlled Trials as Topic; 12. Recurrence; 13. Self Care; 14. Varicose Ulcer [*therapy]; 15. Wound Healing; | Provide MESH terms for the study
Interventions for helping people adhere to compression treatments for venous leg ulceration | You are a research assistant. Based on the question please provide appropriate answers |
1. Calcium Channel Blockers [*therapeutic use]; 2. Nicardipine [therapeutic use]; 3. Nifedipine [therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Raynaud Disease [*drug therapy]; | Provide MESH terms for the study
Calcium channel blockers for primary Raynaud's phenomenon | You are a research assistant. Based on the question please provide appropriate answers |
1. *Sex Counseling; 2. Cardiac Rehabilitation; 3. Cardiovascular Diseases [*complications]; 4. Coronary Artery Bypass; 5. Myocardial Infarction [complications, rehabilitation]; 6. Patient Satisfaction; 7. Randomized Controlled Trials as Topic; 8. Sexual Dysfunction, Physiological [psychology, *rehabilitation]; 9. Sexual Partners; | Provide MESH terms for the study
Sexual counselling for sexual problems in patients with cardiovascular disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Anti‐Inflammatory Agents, Non‐Steroidal [*administration & dosage]; 3. Aspirin [*administration & dosage]; 4. Compression Bandages; 5. Randomized Controlled Trials as Topic; 6. Varicose Ulcer [*drug therapy]; 7. Wound Healing [*drug effects]; | Provide MESH terms for the study
Oral aspirin for treating venous leg ulcers | You are a research assistant. Based on the question please provide appropriate answers |
1. Blood Circulation; 2. Defibrillators; 3. Electric Countershock [*methods, mortality]; 4. Out-of-Hospital Cardiac Arrest [mortality, *therapy]; 5. Randomized Controlled Trials as Topic; 6. Time Factors; 7. Ventricular Fibrillation [*therapy]; | Provide MESH terms for the study
Biphasic versus monophasic waveforms for transthoracic defibrillation in out‐of‐hospital cardiac arrest | You are a research assistant. Based on the question please provide appropriate answers |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.